CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The compa… Read more
Market Cap & Net Worth: CS Diagnostics Corp. (CSDX)
CS Diagnostics Corp. (OTCQB:CSDX) has a market capitalization of $104.12 Million ($104.12 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #28295 globally and #9442 in its home market, demonstrating a -19.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CS Diagnostics Corp.'s stock price $0.42 by its total outstanding shares 249992200 (249.99 Million).
CS Diagnostics Corp. Market Cap History: 2015 to 2025
CS Diagnostics Corp.'s market capitalization history from 2015 to 2025. Data shows change from $1.24 Billion to $104.12 Million (-42.24% CAGR).
CS Diagnostics Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CS Diagnostics Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CSDX by Market Capitalization
Companies near CS Diagnostics Corp. in the global market cap rankings as of March 19, 2026.
Key companies related to CS Diagnostics Corp. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
CS Diagnostics Corp. Historical Marketcap From 2015 to 2025
Between 2015 and today, CS Diagnostics Corp.'s market cap moved from $1.24 Billion to $ 104.12 Million, with a yearly change of -42.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $104.12 Million | -85.64% |
| 2024 | $724.98 Million | +480.00% |
| 2023 | $125.00 Million | -82.14% |
| 2022 | $699.98 Million | +5500.00% |
| 2021 | $12.50 Million | -98.46% |
| 2020 | $812.47 Million | +16.07% |
| 2019 | $699.98 Million | +100.00% |
| 2018 | $349.99 Million | -65.00% |
| 2017 | $999.97 Million | +433.33% |
| 2016 | $187.49 Million | -84.85% |
| 2015 | $1.24 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CS Diagnostics Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.12 Million USD |
| MoneyControl | $104.12 Million USD |
| MarketWatch | $104.12 Million USD |
| marketcap.company | $104.12 Million USD |
| Reuters | $104.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.